Form D · Biotechnology
Boston Interactome, Inc.
Allston, MA · CIK 0002142020
Offering snapshot reported Jun 24, 2026 · SEC filing
- Reported sold
- $500K Offering amount: $1.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 18, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 24, 2026 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-588350
Source: Form D, filed Jun 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Soon Gang Choi | Director, Executive |
| Oliver A. Weisser | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
127 Western Avenue
Allston, MA, 02134
Allston, MA, 02134